Skip to Content

Eventide Healthcare & Life Sciences I ETIHX

Medalist Rating as of | See Eventide Investment Hub
  • NAV / 1-Day Return 33.26  /  0.09 %
  • Total Assets 1.5 Bil
  • Adj. Expense Ratio
    1.310%
  • Expense Ratio 1.310%
  • Distribution Fee Level High
  • Share Class Type Institutional
  • Category Health
  • Investment Style Small Growth
  • Min. Initial Investment 100,000
  • Status Open
  • TTM Yield
  • Turnover 79%

Morningstar’s Analysis ETIHX

Will ETIHX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

This fund's track record comes with plenty of risks.

Senior Analyst David Kathman

David Kathman

Senior Analyst

Summary

Eventide Healthcare & Life Sciences is not a bad option within its narrow niche, though most investors should approach it with caution due to its inherent volatility. It maintains its pillar scores of Above Average for People and Average for Process.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ETIHX

  • Current Portfolio Date
  • Equity Holdings 69
  • Bond Holdings 0
  • Other Holdings 31
  • % Assets in Top 10 Holdings 34.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector
4.72
73,598,518
Healthcare
4.07
63,429,119
Healthcare
3.70
57,759,486
Healthcare
3.69
57,463,546
Healthcare

Us Bank Mmda - Usbgfs 9

3.37
52,618,100
Cash and Equivalents
2.82
44,032,000
Healthcare
2.34
36,466,476
Healthcare
2.32
36,112,758
Healthcare
2.27
35,366,460
Healthcare